Baillie Gifford & CO Axonics, Inc. Transaction History
Baillie Gifford & CO
- $127 Billion
- Q4 2024
Shares
3 transactions
Others Institutions Holding AXNX
# of Institutions
46Shares Held
10.1MCall Options Held
5.2KPut Options Held
58.3K-
Black Rock Inc. New York, NY4.34MShares$308 Million0.01% of portfolio
-
Putnam Investments LLC Boston, MA239KShares$17 Million0.02% of portfolio
-
Segantii Capital Management LTD165KShares$11.7 Million1.41% of portfolio
-
Credit Suisse Ag Zurich, V899.6KShares$7.07 Million0.01% of portfolio
-
Eisler Capital (Uk) Ltd. London, X098.5KShares$6.99 Million0.03% of portfolio
About Axonics, Inc.
- Ticker AXNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 49,123,600
- Market Cap $3.49B
- Description
- Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...